Bank of New York Mellon Corp increased its stake in shares of Univar Inc. (NYSE:UNVR) by 7.5% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 133,692 shares of the company’s stock after buying an additional 9,299 shares during the period. Bank of New York Mellon Corp owned 0.10% of Univar worth $2,529,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in UNVR. Legal & General Group Plc boosted its stake in shares of Univar by 41.5% in the first quarter. Legal & General Group Plc now owns 7,235 shares of the company’s stock valued at $125,000 after buying an additional 2,123 shares in the last quarter. Prudential Financial Inc. purchased a new position in Univar during the first quarter worth $419,000. Barclays PLC boosted its position in Univar by 102,281.0% in the first quarter. Barclays PLC now owns 43,000 shares of the company’s stock worth $731,000 after buying an additional 42,958 shares during the period. A.R.T. Advisors LLC purchased a new position in Univar during the first quarter worth $765,000. Finally, HBK Investments L P purchased a new position in Univar during the first quarter worth $1,100,000. Hedge funds and other institutional investors own 80.17% of the company’s stock.
Shares of Univar Inc. (NYSE:UNVR) traded down 0.46% during mid-day trading on Monday, hitting $21.75. 283,579 shares of the stock were exchanged. Univar Inc. has a 12 month low of $10.65 and a 12 month high of $22.09. The company has a 50-day moving average price of $20.24 and a 200-day moving average price of $18.71. The stock has a market cap of $3.00 billion, a price-to-earnings ratio of 47.49 and a beta of 1.23.
Univar (NYSE:UNVR) last announced its quarterly earnings data on Tuesday, August 9th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.13. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.23 billion. Univar had a return on equity of 7.73% and a net margin of 0.75%. The firm’s revenue for the quarter was down 9.9% on a year-over-year basis. During the same quarter last year, the firm posted ($0.12) EPS. Equities analysts expect that Univar Inc. will post $0.72 earnings per share for the current year.
UNVR has been the topic of a number of analyst reports. Jefferies Group initiated coverage on shares of Univar in a research report on Friday, September 9th. They set a “buy” rating and a $26.00 price objective on the stock. Bank of America Corp. set a $22.00 price objective on shares of Univar and gave the company a “buy” rating in a research report on Thursday, August 11th. Barclays PLC cut shares of Univar from an “overweight” rating to an “equal weight” rating and set a $20.00 price objective on the stock. in a research report on Friday, June 24th. They noted that the move was a valuation call. Wells Fargo & Co. reiterated a “hold” rating on shares of Univar in a research report on Sunday, September 4th. Finally, Zacks Investment Research upgraded shares of Univar from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $22.20.
In other Univar news, major shareholder Nv Univar sold 20,527,358 shares of the firm’s stock in a transaction on Thursday, August 18th. The stock was sold at an average price of $19.00, for a total value of $390,019,802.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Christopher D. Pappas bought 5,000 shares of the business’s stock in a transaction on Friday, August 12th. The stock was bought at an average cost of $19.33 per share, with a total value of $96,650.00. Following the completion of the purchase, the director now directly owns 55,088 shares in the company, valued at $1,064,851.04. The disclosure for this purchase can be found here. 2.49% of the stock is owned by company insiders.
Univar Company Profile
Univar Inc is a distributor of commodity and specialty chemicals. The Company’s segments include Univar USA (USA); Univar Canada (Canada); Univar Europe, the Middle East and Africa (EMEA), and Rest of World. The Rest of World segment includes developing businesses in Latin America, including Brazil and Mexico, and the Asia-Pacific region.
Want to see what other hedge funds are holding UNVR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Univar Inc. (NYSE:UNVR).
Receive News & Ratings for Univar Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Univar Inc. and related companies with MarketBeat.com's FREE daily email newsletter.